CV Sciences (CVSI) Gross Margin (2013 - 2026)
CV Sciences (CVSI) posted Gross Margin of 48.89% for Q1 2026, down 3.25% sequentially from 50.53% in Q4 2025, and up 291.0% YoY from 12.5% in Q1 2025.
CV Sciences (CVSI) Gross Margin (2013 - 2026) Analysis & Trends
CV Sciences has reported Gross Margin for 14 years, with the latest figure at 48.89% in Q1 2026.
- Quarterly Gross Margin rose 291.0% year-over-year to 48.89% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 49.75% (up 420.0% YoY) and the FY2025 annual result came in at 48.97%, up 333.0% from the prior year.
- Gross Margin declined to 48.89% in Q1 2026 per CVSI's latest filing, from 50.53% in the prior quarter.
- Over five years, Gross Margin peaked at 50.94% in Q2 2025 and troughed at 26.0% in Q1 2022.
- A 5-year average of 43.72% and a median of 45.83% in 2023 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2023: Gross Margin plunged 2268 bps in 2022, then surged 1697 bps in 2023.
- Over 5 years, Gross Margin stood at 40.37% in 2022, then gained by 14 bps to 45.83% in 2023, then slipped by 6 bps to 43.18% in 2024, then advanced by 17 bps to 50.53% in 2025, then retreated by 3 bps to 48.89% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 48.89%, 50.53%, and 48.5% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 48.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.58% |
| Mar 31, 2026 | 48.89% |
| Dec 31, 2025 | 50.53% |
| Sep 30, 2025 | 48.50% |
| Jun 30, 2025 | 50.94% |
| Mar 31, 2025 | 45.98% |
| Dec 31, 2024 | 43.18% |
| Sep 30, 2024 | 46.00% |
| Jun 30, 2024 | 47.04% |
| Mar 31, 2024 | 46.30% |
| Dec 31, 2023 | 45.83% |
| Sep 30, 2023 | 45.07% |
| Jun 30, 2023 | 43.32% |
| Mar 31, 2023 | 42.96% |
| Dec 31, 2022 | 40.37% |
| Sep 30, 2022 | 41.64% |
| Jun 30, 2022 | 30.69% |
| Mar 31, 2022 | 26.00% |
| Dec 31, 2021 | 32.40% |
| Sep 30, 2021 | 46.17% |